[1] Jemal A, Siegel R, Ward E,et al. Cancer statistics, 2008.CA Cancer J Clin. 2008;58(2):71-96. [2] Reya T, Morrison SJ, Clarke MF,et al. Stem cells, cancer, and cancer stem cells.Nature. 2001;414(6859):105-111.[3] Jørgensen HG, Holyoake TL. Characterization of cancer stem cells in chronic myeloid leukaemia. Biochem Soc Trans. 2007; 35(Pt 5):1347-1351.[4] Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle. 2004 ;3(4):414-415. [5] Wang J, Guo LP, Chen LZ,et al. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 2007;67(8):3716-3724.[6] ]Kondo T, Setoguchi T, Taga T.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.Proc Natl Acad Sci U S A. 2004;101(3):781-786. [7] Wang J, Guo LP, Chen LZ,et al. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.Cancer Res. 2007;67(8):3716-3724.[8] Christgen M, Ballmaier M, Bruchhardt H,et al. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem. 2007;306(1-2): 201-212. [9] Haraguchi N, Utsunomiya T, Inoue H,et al. Characterization of a side population of cancer cells from human gastrointestinal system.Stem Cells. 2006;24(3):506-513.[10] 吴婷,李锦毅,陆士新.人胃癌侧群细胞的分离鉴定和生物学特性分析[J].中华肿瘤志,2012,34(4):264-268.[11] Chiba T, Kita K, Zheng YW,et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006;44(1):240-251.[12] 吕阳,许戈良,荚卫东,等.肝癌细胞株HepG2中侧群细胞的生物学特性[J].中华实验外科杂志,2013,30(3):500-502.[13] 李新星,王昊陆,王伟,等.人胆囊癌SGC996细胞株侧群细胞的分离与体外培养[J].中华实验外科杂志,2011,28(11):1841-1843.[14] 骆黎静,赵喆,曾建芳,等.卵巢上皮性癌细胞系OVCAR-3侧群细胞的生物学特性分析[J].中华妇产科杂志,2012,47(4):281-285.[15] 李泓馨,赵勇,管海宏,等.ABCG2在人皮肤鳞状细胞癌组织及A431侧群细胞中的表达及意义[J].中华皮肤科杂志,2012,45(6): 392-395.[16] 邢莉莉,沙永亮,吴晔明.神经母细胞瘤SP细胞的分离鉴定及增殖功能分析[J].中华小儿外科杂志,2013,34(5):325-329.[17] 张浩.口腔鳞状细胞癌中SP与NSP细胞的分离与检测[J].北京:首都医科大学,2011.[18] 杨塔娜.胰腺癌细胞系SW1990中SP细胞的分选及表型研究[C].威海:第七届全国胰腺癌研究进展暨规范化诊治学术研讨会论文集,2010.[19] 陈侃,田雪君,陈兴华,等.肝癌细胞系中SP及CD133+细胞的特性分析[J].中国细胞生物学学报,2011,33(3):244-251.[20] 王兵,刘文勇,叶冬霞,等.肠癌SW480肿瘤细胞SP亚群分析[J].上海交通大学学报:医学版,2011,31(8):1113-1116.[21] 焦锋.鼻咽癌细胞系5-8F中SP亚群的检测及其生物学功能的分析[J].广州:南方医科大学,2010.[22] 胡均,柳建中,岳欣,等.人胆囊癌SP细胞的分离及其干细胞标记物的表达[J].中国肿瘤临床,2010,37(1):44-47.[23] 张英,林洪生,祁鑫,等.人乳腺癌MCF-7细胞中SP亚群细胞的分离及其生物学行为研究[J].现代肿瘤医学,2010,18(10): 1879-1885.[24] 潘旋,李艳利,德伟,等.人肺腺癌(LAC)中SP细胞亚群的分选及其干细胞特性分析[J].南京医科大学学报:自然科学版,2010,30(11): 1584-1589.[25] 周静.人胰腺癌肿瘤干细胞样SP细胞的分离鉴定及生物学特性研究[J].武汉:华中科技大学,2009.[26] 杨塔娜,田海梅,李艳芬,等.胰腺癌细胞系SW1990中SP细胞的分选及表型研究[J].中国肿瘤,2009,18(5):409-412.[27] 谢彤,李力,茅乃权,等.人肺腺癌A549细胞系SP细胞亚群的分选及初步探讨[J].广西医科大学学报,2009,26(3):348-352.[28] Matsui W, Wang Q, Barber JP,et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008;68(1):190-197. [29] Kayo H, Yamazaki H, Nishida H,et al. Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma. Biochem Biophys Res Commun. 2007;364(4):808-814.[30] Patrawala L, Calhoun T, Schneider-Broussard R,et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 2005;65(14):6207-6219.[31] Zheng X, Seshire A, Rüster B,et al. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells. Haematologica. 2007;92(3):323-331.[32] 范瑞华,李惠民,李晓进,等.血液肿瘤细胞株中侧群细胞的检测和分选[J].中国组织工程研究与临床康复,2010,14(10): 1821-1824.[33] 岳保红,张秋堂,秦东春,等. K562和HL60细胞分化抗原的表达[J].郑州大学学报:医学版,2006,41(3):467-471.[34] Holyoake TL, Jiang X, Drummond MW,et al. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia. 2002;16(4):549-558.[35] Jamieson CH, Ailles LE, Dylla SJ,et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004 ;351(7): 657-667.[36] Minami Y, Stuart SA, Ikawa T,et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci U S A. 2008;105(46):17967-17972.[37] Feuring-Buske M, Hogge DE. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia. Blood. 2001;97(12):3882-3889.[38] Fang B, Zheng C, Liao L,et al. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood. 2005;105(7):2733-2740. [39] Gunsilius E. Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Adv Exp Med Biol. 2003;522:17-24. |